Skip to main content
. 2011 Jan 17;96(5):681–686. doi: 10.3324/haematol.2010.034074

Figure 1.

Figure 1.

(A) Survival after relapse for all patients. (B) Survival after relapse according to age. Solid line: patients <47 years (n=46); dotted line: patients ≥ 47 years (n=48); P=0.001. (C) Survival after disease according to FLT3-ITD. Solid line: patients without FLT3-ITD (n=64); dotted line: patients with FLT3-ITD (n=30); P=0.001.